Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
Take Tell Us What YOU Think! Take The Body's Visitor Survey!
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Prevention/Epidemiology

Calypte HIV Test Gets OK in Kenya

From U.S. Centers for Disease Control and Prevention

March 30, 2006

On Tuesday, Calypte Biomedical Corp. said its oral and blood rapid-result HIV tests have been approved for sale in Kenya. Kenya, a nation of more than 30 million, including 1.2 million HIV-positive people, now has more than 350 registered sites where residents can receive HIV testing and counseling. The approval means Calypte can compete for Kenyan government contracts, anticipated to be announced later this year, for more than 4 million tests. The company said the United States is expected to provide more than $200 million in HIV/AIDS funding this year for Kenya, which is one of the 15 nations targeted by President Bush's Emergency Plan for AIDS Relief.

Back to other news for March 30, 2006

Adapted from:
Associated Press
03.28.2006

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
Kenya

 

Advertisement